Clinical Trial Update: Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the safety and preliminary efficacy of the radiolabeled anti-B1 monoclonal antibody (Coulter Clone 131Iodine-B1) for advanced No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Coulter Clone 131Iodine-B1 (Iodine-131-labeled anti-B1 monoclonal antibody)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 1 | Status: COMPLETED | Results posted: 2012-03-30